| [1] |
Hussein RA, El-Anssary AA. 2019. Plants secondary metabolites: the key drivers of the pharmacological actions of medicinal plants. In Herbal Medicine, ed. Builders PF. London: IntechOpen. pp. 11−30 doi: 10.5772/intechopen.76139 |
| [2] |
Latif R, Nawaz T. 2026. Medicinal plants and human health: a comprehensive review of bioactive compounds, therapeutic effects, and applications. |
| [3] |
Lin YL, Huang RL, Don MJ, Kuo YH. 2000. Dihydrophenanthrenes from Spiranthes sinensis. |
| [4] |
Liu J, Li CY, Zhong YJ, Yang L, Li YF. 2013. Chemical constituents from Spiranthes sinensis. |
| [5] |
Yan Y, Wu C, Zhou H, Feng X, Li YF. 2019. Secondary metabolites from Spiranthes sinensis (Orchidaceae). |
| [6] |
Kuo YJ, Pei JK, Chao WW. 2022. Pharmacological and chemical potential of Spiranthes sinensis (Orchidaceae): a narrative review. |
| [7] |
Li CY, Liu J, Su XH, Yuan ZP, Zhong YJ, et al. 2013. New dimeric phenanthrene and flavone from Spiranthes sinensis. |
| [8] |
Tezuka Y, Nagashima K, Hirano H, Kikuchi T. 1989. Spiranthesol, a dimeric dihydrophenanthrene from the roots of Spiranthes sinensis (Pers.) Ames var. amoena (M. Bieberson) Hara. |
| [9] |
Tezuka Y, Ji L, Hirano H, Ueda M, Nagashima K, et al. 1990. Studies on the constituents of orchidaceous plants. IX. Constituents of Spiranthes sinensis (Pers.) Ames var. amoena (M. Bieberson) Hara. (2). Structures of spiranthesol, spiranthoquinone, spiranthol-C, and spirasineol-B, new isopentenyldihydrophenanthrenes. |
| [10] |
Ji M, Wang Y, Wang Y, Zhang X, Liu C, et al. 2025. A new dihydrophenanthrene with cell viability enhancing activities from Spiranthes sinensis. |
| [11] |
Kovács A, Vasas A, Hohmann J. 2008. Natural phenanthrenes and their biological activity. |
| [12] |
Shie PH, Yang CP, Huang GJ, Wang SY, Kuo YH. 2020. Sinensol-C isolated from Spiranthes sinensis inhibits adipogenesis in 3T3-L1 cells through the regulation of adipogenic transcription factors and AMPK activation. |
| [13] |
Liang CP, Chang CH, Liang CC, Hung KY, Hsieh CW. 2014. In vitro antioxidant activities, free radical scavenging capacity, and tyrosinase inhibitory of flavonoid compounds and ferulic acid from Spiranthes sinensis (Pers.) Ames. |
| [14] |
Peng JY, Han X, Xu LN, Qi Y, Xu YW, et al. 2008. Two new prenylated coumarins from Spiranthes sinensis (Pers.) Ames. |
| [15] |
Zou M, Wang R, Yin Q, Liu L. 2021. Bioassay-guided isolation and identification of anti-Alzheimer's active compounds from Spiranthes sinensis (Pers.) Ames. |
| [16] |
Li Y, Zhao W, Zuo X, You J, Xing M, et al. 2025. Habitat changes due to cultivation alter the genetic diversity and secondary metabolic changes of medicinal plants. |
| [17] |
Turker H. 2025. Investigation of the physiological and antioxidant properties of the medicinal and endemic Hypericum bilgehan-bilgilii species under different cultivation methods. |
| [18] |
Hou C, Huang L, Li Z, Sun N, Yang S, et al. 2024. Domestication of medicinal plants (Lonicera japonica Thunb.) in China: comparison of morphological, resistance and biochemical traits between wild and cultivated populations. |
| [19] |
Hao Y, Zhang Z, Luo E, Yang J, Wang S. 2025. Plant metabolomics: applications and challenges in the era of multi-omics big data. |
| [20] |
Pace MC, Giraldo G, Frericks J, Lehnebach CA, Cameron KM. 2019. Illuminating the systematics of the Spiranthes sinensis species complex (Orchidaceae): ecological speciation with little morphological differentiation. |
| [21] |
Yu G, Wang LG, Han Y, He QY. 2012. clusterProfiler: an R package for comparing biological themes among gene clusters. |
| [22] |
The Gene Ontology Consortium, Aleksander SA, Balhoff J, Carbon S, Cherry JM, et al. 2023. The gene ontology knowledgebase in 2023. |
| [23] |
Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. 2023. KEGG for taxonomy-based analysis of pathways and genomes. |
| [24] |
Wang FP, Chen LJ, Zhou SR, Tang M, Zhang X, et al. 2025. Integrated metabolomic and transcriptomic analyses reveal temporal dynamics of secondary metabolite accumulation in Cibotium barometz rhizome. |
| [25] |
Padhee S, Kerry RG, Champati BB, Mohanty D, Mohanty S, et al. 2026. Medicinal orchids as anti-inflammatory agents: phytochemistry and molecular mechanisms of action. |
| [26] |
Tóth B, Hohmann J, Vasas A. 2018. Phenanthrenes: a promising group of plant secondary metabolites. |
| [27] |
Wu X, Yuan Y, Yang Y, Yan M, Yang Q, et al. 2026. Comparative metabolomics and transcriptomics analysis of Rosa roxburghii tratt and Rosa kweichonensis var. sterilis. |
| [28] |
Liu L, Li Q, Alami M, Shen R, Zhu J, et al. 2026. Comparison of metabolite differences and pharmacologically active constituents between Piper longum and Piper sarmentosum based on non-targeted metabolomics. |
| [29] |
Bacler-Żbikowska B, Hutniczak A, Pilawa B, Chodurek E, Zdybel M, et al. 2025. The current state of knowledge about changes in the synthesis of the secondary metabolites caused by habitat conditions and microbial activity. |
| [30] |
Fernie AR, Stitt M. 2012. On the discordance of metabolomics with proteomics and transcriptomics: coping with increasing complexity in logic, chemistry, and network interactions scientific correspondence. |
| [31] |
Bernstein N, Gorelick J, Zerahia R, Koch S. 2019. Impact of N, P, K, and humic acid supplementation on the chemical profile of medical cannabis (Cannabis sativa L). |
| [32] |
Simonutti M, Berhongaray G, Derita M, Zabala JM. 2025. Response of Cannabis sativa L. to inorganic fertilization (N, P, K): biomass, nutrient uptake and cannabinoids profile. |
| [33] |
Song F, Fu D, Wang A, Yang Z, Yu T. 2026. Effects of different cultivation methods on the rhizosphere microbial community and secondary metabolites of Houttuynia cordata Thunb. |